Skip to content

SABSW

SAB Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.01
−7.89%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
0.60x

Trailing multiples

Trailing twelve months

P/E TTM
0.00x
PEG TTM
Price / book
0.00x
Price / sales
Price / cash flow
-0.00x

Enterprise value

Enterprise value
-$97.4M
EV / sales
EV / EBITDA
10.29x
EV / EBIT
1.36x
Market cap
$149.2K

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026